• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


How's The Old New England Region Doing?





Makes perfect sense...oh wait, they all just got promoted!

So if they used DCS reps in Boston and their was no negative impact that would mean that the "new business model" was just BS? We know that they basically see no one and just keep the secret so that management still has a job along with the reps.